On February 15th, FDA issued the first MDC for MESA client AMC Pharma, USA. AMC's ArtemiC Rescue uses safe and proven antioxidants to reduce the severity and duration of COVID-19. Based on the findings from several hospital-based clinical trials, this OTC compound showed that ArtemiC Rescue significantly reduces the incidence of cytokine storm in patients who were tested and diagnosed with COVID-19. Cytokine storm is one of the most prevalent reasons why coronavirus kills COVID patients. MESA is excited about it's continued work with AMC Pharma as AMC brings additional drugs and supplements to the US market.
MESA surgical consultants provide simple and achievable evidence based methods to eliminate the root cause for serious safety events in all perioperative areas. These include wrong site procedures, accidental punctures, medication errors, and other issues that harm patients.
MESA consultants lead its clients through construction projects totaling more than a billion dollars. From small clinics to 1000 bed teaching hospitals, MESA acted as consultants and project managers. Our strategic partners allow us to provide turnkey construction for any size healthcare construction project. If you are considering construction you should contact us today!
If your CEO isn't getting messages like this, call MESA today. MESA's surgeon-centric approach to surgeon satisfaction has been deployed in over 1000 U.S. hospitals.
Sign up to hear from us.
Copyright © 2018 Mesa Healthcare, Inc - All Rights Reserved.
Powered by GoDaddy Website Builder
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.